10 Followers on Owler

Abivax

is a France-based biotechnology company that researches and develops novel therapeutics for the treatment of cancer, viral and inflammatory diseases... Read more
OverviewCompetitorsFundingNews & Insights

Abivax

is a France-based biotechnology company that researches and develops novel therapeutics for the treatment of cancer, viral and inflammatory diseases... Read more
Abivax CEO: Marc de Garidel

CEO

Marc de Garidel

CEO Approval Rating

82/100

2013

PublicNASDAQABVX

Pharmaceuticals & Biotechnology
Biotechnology
2836 NAICS listing

Annual Revenue
$ < 1M
Employees
22
Funding
$2.7B

News

Partnership
Jul 16, 2026
Marketscreener
Valerio Therapeutics Announces Development Collaboration with Abivax and Provides Pipeline Update
Funding
Jul 02, 2026
ir.abivax.com
Abivax received $920M in Post-IPO Equity Funding

Abivax Competitors

1GENFIT
2Innate Pharma
3Quantum Genomics
4Kite Pharma
5Cellectis
6Orbsen Therapeutics
7OncBioMune
8Cirius Therapeutics
9Miracor Medical SA
10Juno Therapeutics
Unlock 25 + competitors

Trending Companies